Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Ammonium lauryl sulfate: Applications and Toxic Mechanism
Ammonium lauryl sulfate enhances fuel cells and latex production but poses health risks due to mitochondrial-induced apoptosis.
Nov 19,2024 APIBaricitinib: Clinical Efficacy and Safety
Baricitinib is effective for Alopecia Areata and has a favorable safety profile, supporting its use in atopic dermatitis treatment.
Nov 19,2024 APIKetorolac Tromethamine Injection and Ketorolac tromethamine tablets
Ketorolac tromethamine (Acular), approved in November 1992, is one of the earliest prescription products for treating itch associated with allergic conjunctivitis.
Nov 19,2024 APIBrigatinib: Development History and Preclinical Studies
Brigatinib, a crucial treatment for NSCLC patients with EGFR and ALK mutations, effectively inhibits ALK with unique features, overcoming resistance and offering hope in lung cancer treatment.
Nov 19,2024 APIAlpha-Amylase: A Key Enzyme in Chemistry and Biotechnology
Alpha-amylase, has garnered significant attention due to its vital role in catalyzing the hydrolysis of starch into sugars.
Nov 19,2024 APIExploring Sodium Monofluorophosphate: Chemical Properties, Applications, and Safety
Sodium monofluorophosphate is an inorganic compound that has gained widespread attention, particularly in the fields of oral hygiene and chemistry.
Nov 19,2024 APISuccinic Anhydride: Applications in Surface Modification and Sustainable Production
Sustainable production of succinic anhydride from biomass using visible light-induced oxygenation with H2TPP enhances CNC properties in polymeric nanocomposites.
Nov 18,2024 APIEthyl Vanillin: Pharmacokinetic Properties and Toxicity
Ethyl vanillin, a common flavoring, undergoes rapid metabolism, potentially causing toxicity at high doses, necessitating careful regulation for safety in food and drug applications.
Nov 18,2024 APIFuraneol: Biosynthesis and Pharmacological Activities
Furaneol, synthesized by yeast and bacteria in fermented soy sauce, possesses antimicrobial properties and activates odor receptors.
Nov 18,2024 APIPolymyxin B Sulfate: A Critical Antibiotic for Combating Multidrug-Resistant Gram-Negative Bacteria
Polymyxin B sulfate is a critically important antimicrobial agent, especially for combating infections caused by multidrug-resistant Gram-negative bacteria.
Nov 18,2024 API